Decades of subtle health changes went by without answers. When worsening disability led Roger to a multiple sclerosis (MS) ...
A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...
Irish Star on MSN6h
Groundbreaking new blood test can tell you what diseases you could get in a decadeA groundbreaking study analyzing how levels of up to 5,400 proteins circulating in our body change in mid-to-late life and ...
After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to a study published online in Neurology.
The researchers found that a biomarker in the blood called neurofilament light chain (NfL) increased after menopause. This ...
Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...
Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback